HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection

Natural killer (NK) cells provide a central defense against viral infection by using inhibitory and activation receptors for major histocompatibility complex class I molecules as a means of controlling their activity. We show that genes encoding the inhibitory NK cell receptor KIR2DL3 and its human leukocyte antigen C group1 (HLA-C1) ligand directly influence resolution of hepatitis C virus (HCV) infection. This effect was observed in Caucasians and African Americans with expected low infectious doses of HCV but not in those with high-dose exposure, in whom the innate immune response is likely overwhelmed. The data strongly suggest that inhibitory NK cell interactions are important in determining antiviral immunity and that diminished inhibitory responses confer protection against HCV.

[1]  D. G. Muir,et al.  Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans. , 2000, Immunity.

[2]  P Parham,et al.  Human diversity in killer cell inhibitory receptor genes. , 1997, Immunity.

[3]  R. Lanford,et al.  DNA Microarray Analysis of Chimpanzee Liver during Acute Resolving Hepatitis C Virus Infection , 2001, Journal of Virology.

[4]  H. Ljunggren,et al.  In search of the 'missing self': MHC molecules and NK cell recognition. , 1990, Immunology today.

[5]  L. Lanier,et al.  Direct Recognition of Cytomegalovirus by Activating and Inhibitory NK Cell Receptors , 2002, Science.

[6]  Keith Hoots,et al.  Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS , 2002, Nature Genetics.

[7]  N. Letvin,et al.  Diversity of the Killer Cell Ig-Like Receptors of Rhesus Monkeys1 2 , 2001, The Journal of Immunology.

[8]  A. Scalzo,et al.  Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen , 1990, The Journal of experimental medicine.

[9]  M. Yu,et al.  Hepatitis C virus RNA in factor VIII concentrates , 1995, Transfusion.

[10]  P. Simmonds,et al.  Hepatitis C quantification and sequencing in blood products, haemophiliacs, and drug users , 1990, The Lancet.

[11]  H. Ljunggren,et al.  Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy , 1986, Nature.

[12]  J. Goedert,et al.  HLA-Cw*04 and Hepatitis C Virus Persistence , 2002, Journal of Virology.

[13]  Daniel J. Schaid,et al.  Major Histocompatibility Complex Class I–Recognizing Receptors Are Disease Risk Genes in Rheumatoid Arthritis , 2001, The Journal of experimental medicine.

[14]  Eric O Long,et al.  Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. , 1998, Journal of immunology.

[15]  P. Leibson,et al.  Natural killer cell activation in mice and men: different triggers for similar weapons? , 2002, Nature Immunology.

[16]  B. Rehermann,et al.  Hepatitis C virus infection: when silence is deception. , 2003, Trends in immunology.

[17]  E. Adams,et al.  Evidence for an HLA-C-like locus in the orangutan Pongo pygmaeus , 1999, Immunogenetics.

[18]  S. Nuti,et al.  Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein , 2002, The Journal of experimental medicine.

[19]  Michael J. Wilson,et al.  Cutting Edge: Susceptibility to Psoriatic Arthritis: Influence of Activating Killer Ig-Like Receptor Genes in the Absence of Specific HLA-C Alleles1 , 2002, The Journal of Immunology.

[20]  D. Vlahov,et al.  The natural history of hepatitis C virus infection: host, viral, and environmental factors. , 2000, JAMA.

[21]  P Parham,et al.  Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. , 1997, Immunity.

[22]  A Steinle,et al.  Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. , 1999, Science.